Delivery Order SPE2DB24D3015-SPE2DB24FFXDR

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs) with federal agencies, including a single-award IDC with DLA Troop Support Medical valued up to $999,999,999.00 through 2025. This specific delivery order is valued at $11,859.56 and has...
The U.S. Defense Logistics Agency (DLA) awarded a $1,233.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565664445 - Cyclosporine 0.05% eye emulsion. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of the prime contractor, Amerisourcebergen Drug Corp. The contract has a ceiling value of $69,647.98 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently procure a comprehensive range of medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Cyclosporine 0.05% eye emulsion. The contract, valued at $1,029.62, was awarded by the Defense Logistics Agency (DLA) as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen. The IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a range of pharmaceutical products and medical supplies to DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,107.27 firm fixed price contract has an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive range...
This is a $2,658.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4563239582 - Cyclosporine 0.05% Eye Emulsion, 60s, with a performance period ending on January 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cyclosporine 0.05% eye emulsion. The $2,168.64 firm-fixed-price Delivery Order has a completion date of July 25, 2024 and is not designated as a set-aside contract. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award is for $7,424.52 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which serves as a primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award, valued at $9,653.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product, with a completion date of January 15, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $8,250.79 firm fixed-price contract is for the supply of 4565828110 - Cyclosporine 0.05% Eye Emulsion 60s, a specialty pharmaceutical product. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB24FFXDR
    Delivery Order

This federal contract award is an $1,533.69 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 60 units of cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the government to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by August 6, 2024.

Generated 11/4/24, 11:12 AM